This month, Mölnlycke Health Care has been attending, hosting dedicated events and been platinum sponsor at the 17th Congress of the International Society for Burn Injuries in Sydney, Australia, aka ISBI, which has run from 12-16 October.
The overall theme of the conference was "Improving the Quality of Burn Care Outcomes: Managing the Wound and Its Consequences".
The ISBI and Australian and New Zealand Burn Association (ANZBA) brought together international and Australian health professionals for an innovative, multidisciplinary congress.
As well as hosting and meeting delegates at the stand with the message "Leading the way in innovation and evidence", Mölnlycke Health Care hosted two dedicated events.
The first was a symposium on "Evidence on paediatric burn management: How to reduce pain and costs while improving clinical outcomes", chaired by Prof Kamolz. The speakers were Dr Paul Glat, Prof Folke Sjöberg and Dr Kellie Stockton. This event attracted a massive 180 attendees.
The second was a scientific session, the Mölnlycke Health Care Twilight Scientific Forum at Doltone House in Hyde Park, Sydney. The panel members were Dr John Harvey (Australia), Dr Umesh Shah (India), Prof Lars-Peter Kamolz (Austria), Dr Jonathan Heather, (New Zealand) and Dr Paul Glat (USA). 140 customers attended the event.
Mölnlycke Health Care was at the congress to present our comprehensive burn offering and create awareness of the width of the portfolio in four key solution areas; skin grafting, antimicrobial, paediatric and post burn care solutions.
It also gave the company an opportunity to talk about new products launches; Mepilex® Transfer Ag and new bigger sizes of Mepitel One as well as the all-important opportunity to build and strengthen relationships with our partners, like-minded organisations and customers.
For further information on the event, please visit ISBI event website.
And to find out more about the ISBI, International Society For Burn Injuries, please visit ISBI official website.